inflammatory%20bowel%20disease
INFLAMMATORY BOWEL DISEASE
Inflammatory bowel disease consists of ulcerative colitis and Crohn's disease.
Ulcerative colitis is a diffuse mucosal inflammation limited to the colon while Crohn's disease is a patchy, transmural inflammation that occurs in any part of the gastrointestinal tract.
The ileum and colon are the most frequently affected sites.
  1. Carter MJ, Lobo AJ, Travis SPL; IBD Section of the British Society of Gastroenterology. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2004 Sep;53(Suppl 5):v1-16. PMID: 15306569
  2. Dignass A, Eliakim R, Magro F, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohns Colitis. 2012 Dec;6(10):965-990. doi: 10.1016/j.crohns.2012.09.003. PMID: 23040452
  3. Dignass A, Lindsay JO, Sturm A, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management. Oct 04, 2012. J Crohns Colitis. 2012 Dec;6(10):991-1030. http://www.ncbi.nlm.nih.gov. PMID: 23040451
  4. Feldman PA, Wolfson D, Barkin JS. Medical management of Crohn's disease. Clin Colon Rectal Surg. 2007 Nov;20(4):269-281. doi: 10.1055/s-2007-991026. PMID: 20011423
  5. Knutson D, Greenberg G, Cronau H. Management of Crohn's disease - a practical approach. Am Fam Physician. 2003 Aug;68(4):704-714. http://www.ncbi.nlm.nih.gov/pubmed/?term=12952387. PMID: 12952387
  6. Hanauer SB, Sandborn W. Management of Crohn's disease in adults. Am J Gastroenterol. 2001 Mar;96(3):635-643. PMID: 11280528
  7. Kumar R, Singh J. The emerging therapy with prebiotics in the management of inflammatory bowel disease: current status. Int J Basic Clin Pharmacol. 2013;2(4):360-367. Accessed 25 Sep 2013
  8. Kornbluth A, Sachar DB and The Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2010 Mar;105(3):501-523. doi: 10.1038/ajg.2009.727. PMID: 20068560
  9. Leighton JA, Shen B, Baron TH, et al; Standards of Practice Committee, American Society for Gastrointestinal Endoscopy. ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease. Gastrointest Endosc. 2006 Apr;63(4):558-565. PMID: 16564852
  10. Lichtenstein GR, Abreu MT, Cohen R, et al. American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Gastroenterology. 2006 Mar;130(3):940-987. PMID: 16530532
  11. Lichtenstein GR, Hanauer SB, Sandborn WJ; Practice Parameters Committee of American College of Gastroenterology. Management of Crohn's disease in adults. Jan 06, 2009. Am J Gastroenterol. 2009 Feb;104(2):465-483. http://www.ncbi.nlm.nih.gov/pubmed/?term=19174807. PMID: 19174807
  12. Panes J, Bouhnik Y, Reinisch W, et al. Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis. 2013 Aug;7(7):556-585. doi: 10.1016/j.crohns.2013.02.020. PMID: 23583097
  13. Mowat C, Cole A, Windsor A, et al; IBD Section of the British Society of Gastroenterology. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2011 May;60(5):571-607. doi: 10.1136/gut.2010.224154. PMID: 21464096
  14. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002 Aug;347(6):417-429. PMID: 12167685
  15. Sandborn WJ, Fazio VW, Feagan BG, Hanauer SB; American Gastroenterological Association Clinical Practice Committee. AGA technical review on perianal Crohn's disease. Gastroenterology. 2003 Nov;125(5):1508-1530. PMID: 14598268
  16. Siegel CA, Sands BE. Review article: practical management of inflammatory bowel disease patients taking immunomodulators. Aliment Pharmacol Ther. 2005 Jul;22(1):001-16. PMID: 15963074
  17. Strong SA, Koltun WA, Hyman NH, Buie WD; Standards Practice Task Force of The American Society of Colon and Rectal Surgeons. Practice parameters for the surgical management of Crohn's disease. Dis Colon Rectum. 2007 Nov;50(11):1735-1746. PMID: 17690937
  18. Turner D, Travis SP, Griffiths AM, et al; European Crohn’s and Colitis Organization; Porto IBD Working Group, European Society of Pediatric Gastroenterology, Hepatology, and Nutrition. Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN. Am J Gastroenterol. 2011 Apr;106(4):574-588. doi: 10.1038/ajg.2010.481. PMID: 21224839
  19. MedWormhttp://www.medworm.com/rss/index.php/Gastroenterology/17/http://www.medworm.com/rss/medicalfeeds/specialities/Gastroenterology.xml
  20. MedWormhttp://www.medworm.com/rss/index.php/Pediatrics/33/http://www.medworm.com/rss/medicalfeeds/specialities/Pediatrics.xml
  21. Peppercorn MA. Clinical manifestations, diagnosis and prognosis of Crohn's disease in adults. UpToDate. http://www.uptodate.com/index. Feb 2011. Accessed 03 Jun 2011
  22. Chan J. A review on the management of Crohn's disease. US Pharmacist. http://www.uspharmacist.com. Jan 2007. Accessed 16 Jun 2011.
  23. Peppercorn MA, Odze RD. Colorectal cancer surveillance in inflammatory bowel disease. UpToDate. http://www.uptodate.com/index. Aug 2010. Accessed 28 Jul 2011
  24. Peppercorn MA. Clinical manifestations, diagnosis and prognosis of ulcerative colitis in adults. UpToDate. http://www.uptodate.com/index. Jan 2011. Accessed 03 Jun 2011
  25. Crohn's disease. http://www.accessmedicine.com. 2004. Accessed 27 Apr 2005
  26. National Institute for Health and Care Excellence. Crohn's disease: Management in adults, children and young people. NICE. http://www.nice.org.uk. 2012. Accessed 10 Jul 2013.
  27. National Institute for Health and Care Excellence. Guidance on the use of infliximab for Crohn's disease. NICE. http://www.nice.org.uk. 2002. Accessed 30 Sep 2005
  28. Rowe WA. Inflammatory bowel disease. eMedicine. http://emedicine.medscape.com. Jun 2011. Accessed 18 Jul 2011
  29. National Guideline Clearinghouse (NGC). Guideline summary: practice parameters for the surgical treatment of ulcerative colitis. http://www.guideline.gov. 18 Jul 2011
  30. World Gastroenterology Organisation Global Guidelines. Inflammatory bowel disease: a global perspective. http://www.worldgastroenterology.org. Jun 2009.
  31. National Institute for Health and Care Excellence. Infliximab (review) and adalimumab for the treatment of Crohn’s disease. NICE. http://www.nice.org.uk. 2011. Accessed 09 Jul 2013.
  32. Desimone EM, Lanspa SJ, Hogrefe D, et al. Management and treatment of Crohn's disease. US Pharmacist. http://www.uspharmacist.com. 2004. Accessed 27 Apr 2005.
  33. Peppercorn MA, Farrell RJ. Medical management of ulcerative colitis. UpToDate. http://www.uptodate.com/index. Nov 2010. Accessed 03 Jun 2011
  34. Farrell RJ, Peppercorn MA. Overview of the medical management of mild to moderate Crohn's disease in adults. UpToDate. http://www.uptodate.com/index. 27 Apr 2011. Accessed 03 Jun 2011
  35. Centers for Disease Control and Prevention. Inflammatory Bowel Disease. CDC. http://www.cdc.gov/ibd/. 14 Jan 2014. Accessed 10 Apr 2014.
  36. MacDermott RP. Management of mild to moderate ulcerative colitis. UpToDate. http://www.uptodate.com. 13 Feb 2013.
  37. Peppercorn MA, Kane SV. Patient information: ulcerative colitis (beyond the basics). UpToDate. http://www.uptodate.com. 18 Dec 2013.
  38. Travis SP, Danese S, Kupcinskas L, et al. Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study. Gut. 2014 Mar;63(3):433-441. doi: 10.1136/gutjnl-2012-304258. Accessed 08 Apr 2014. PMID: 23436336
  39. Bernstein C, Eliakim A, Fedail S, et al. Inflammatory bowel disease. World Gastroenterology Organisation website. http://www.worldgastroenterology.org/UserFiles/file/guidelines/inflammatory-bowel-disease-english-2015.pdf. Aug 2015.
  40. Peppercorn MA, Odze RD. Colorectal cancer surveillance in inflammatory bowel disease. UpToDate. http://www.uptodate.com. 18 Feb 2015. Accessed 28 Jun 2016.
  41. Peyrin-Biroulet L, Panes J, Sandborn WJ, et al. Defining disease severity in inflammatory bowel diseases: current and future directions. Clin Gastroenterol Hepatol. 2016 Mar 11;14(3):348-354. http://dx.doi.org/10.1016/j.cgh.2015.06.001.
  42. Gomollón F, Dignass A, Annese V, et al. 3. European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: part 1: diagnosis and medical management. J Crohns Colitis. 2016 Sep 22. doi: 10.1093/ecco-jcc/jjw168. PMID: 27660341
  43. Gionchetti P, Dignass A, Danese S, et al. 3. European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: part 2: surgical management and special situations. J Crohns Colitis. 2016 Sep 22. doi: 10.1093/ecco-jcc/jjw169. PMID: 27660342
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 13 Feb 2019
The Mandarin-speaking population in Singapore (SG) has deemed the translated Chronic Liver Disease Questionnaire (CLDQ) culturally acceptable, with only two items that needed revision in the finalized CLDQ-SG, according to a recent study.
Rachel Soon, 30 Sep 2016

Understanding the factors which induce visceral hypersensitivity (VH) in patients with functional gastrointestinal disorders (FGIDs) may help doctors manage patients and develop new treatments, says an expert.

Dr. Angela V. Ignacio, 21 Feb 2017
Administration of a probiotic appears to be a safe and effective therapeutic alternative for minimal hepatic encephalopathy (MHE) in patients with liver cirrhosis, according to a Greek study presented at the 26th Conference of the Asian Pacific Association for the Study of the Liver (APASL) held in Shanghai, China.